Brian M. Wolpin

Brian M. Wolpin

Oncology
450 Brookline Avenue
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 258 publications

Daraxonrasib in Advanced RAS-Mutated Pancreatic Cancer. Reply.

Daraxonrasib in Advanced RAS-Mutated Pancreatic Cancer. Reply.

Journal: The New England journal of medicine
Published: July 22, 2026

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer.

Journal: The New England journal of medicine
Published: June 01, 2026

Risk of Pancreatic Cancer Associated With Precursor Lesions in Individuals and First-Degree Relatives: A Nationwide Cohort Study.

Risk of Pancreatic Cancer Associated With Precursor Lesions in Individuals and First-Degree Relatives: A Nationwide Cohort Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: May 20, 2026

Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.

Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer.

Journal: The New England journal of medicine
Published: May 06, 2026

Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals.

Novel Genetic Risk Loci for Pancreatic Ductal Adenocarcinoma Identified in a Genome-wide Study of African Ancestry Individuals.

Journal: medRxiv : the preprint server for health sciences
Published: May 04, 2026

Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer.

Characterization and therapeutic suppression of KEAP1-NRF2-driven resistance to KRAS inhibitors in pancreatic and lung cancer.

Journal: bioRxiv : the preprint server for biology
Published: May 04, 2026

Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification.

Cell-free chromatin epigenomic profiling enables non-invasive pancreatic cancer cell-state identification.

Journal: medRxiv : the preprint server for health sciences
Published: April 20, 2026

Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus.

Integrative screening identifies functional variants and VNTRs underlying GWAS signals at the 5p15.33 multi-cancer susceptibility locus.

Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026

Imaging and management of biliary complications after biliary interventions.

Imaging and management of biliary complications after biliary interventions.

Journal: Abdominal radiology (New York)
Published: March 13, 2026

Pancreatic cancer-associated organ dysfunction promotes muscle autophagy and contributes to peripheral tissue wasting.

Pancreatic cancer-associated organ dysfunction promotes muscle autophagy and contributes to peripheral tissue wasting.

Journal: bioRxiv : the preprint server for biology
Published: March 11, 2026

Integrated inference of cancer gene expression from cell-free plasma chromatin.

Integrated inference of cancer gene expression from cell-free plasma chromatin.

Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026

Integrated inference of cancer gene expression from cell-free plasma chromatin.

Integrated inference of cancer gene expression from cell-free plasma chromatin.

Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Showing 1-12 of 258

Last Updated: 09/26/2026